Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
25.90
+2.55 (10.92%)
At close: Mar 9, 2026, 4:00 PM EDT
25.50
-0.40 (-1.54%)
After-hours: Mar 9, 2026, 7:59 PM EDT
RGC Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 12,807 | 8,426 | 44 | 300 | 450 | - | |
| Market Cap Growth | 23905.04% | 19171.44% | -85.42% | -33.42% | - | - | |
| Enterprise Value | 12,803 | 8,418 | 39 | 284 | 452 | - | |
| Last Close Price | 25.90 | 17.04 | 0.09 | 0.61 | 0.91 | - | |
| PB Ratio | 2635.09 | 1733.67 | 5.32 | 25.01 | 26.36 | - | |
| P/TBV Ratio | 2635.09 | 1733.67 | 5.32 | 24.92 | 26.39 | - | |
| Debt / Equity Ratio | 0.11 | 0.11 | 0.01 | 0.04 | 0.05 | -0.92 | |
| Net Debt / Equity Ratio | -0.90 | -0.90 | -0.96 | -0.93 | -0.92 | -0.91 | |
| Net Debt / EBITDA Ratio | 1.18 | 1.18 | 1.78 | 1.86 | 2.10 | -2.67 | |
| Net Debt / FCF Ratio | 1.33 | 1.33 | 1.97 | 2.23 | 2.59 | -4.72 | |
| Quick Ratio | 7.38 | 7.38 | 41.13 | 19.06 | 28.42 | 0.01 | |
| Current Ratio | 7.39 | 7.39 | 41.92 | 19.15 | 28.46 | 0.02 | |
| Return on Equity (ROE) | -54.81% | -54.81% | -43.18% | -41.71% | -116.10% | - | |
| Return on Assets (ROA) | -33.20% | -33.20% | -28.11% | -25.59% | -51.87% | -202.15% | |
| Return on Capital Employed (ROCE) | -74.00% | -74.00% | -57.50% | -52.20% | -43.70% | 34.60% | |
| Earnings Yield | -0.03% | -0.04% | -9.84% | -1.96% | -1.65% | - | |
| FCF Yield | -0.03% | -0.04% | -9.16% | -1.66% | -1.34% | - | |
| Buyback Yield / Dilution | - | - | - | -1.62% | -28.06% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.